Krystal Biotech, Inc. (KRYS)
Across 30 earnings reports since Nov 14, 2017, Krystal Biotech, Inc. (KRYS) has a clear post-earnings pattern. It moves ±6.30% on average after reporting and finishes higher 43.3% of the time. Its largest post-earnings gain was +41.02% (Feb 26, 2024) and its largest decline was -15.05% (Nov 06, 2023). The next earnings report is predicted for 2026-08-04 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
30
Avg Abs. Movement
±6.30%
Positive %
43.3%
Negative %
56.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | ☀ PRE | $289.00 | $298.30 | $287.84 | 842,500 | +4.12% | open_in_new |
| Nov 03, 2025 | ☀ PRE | $197.75 | $198.98 | $197.85 | 633,900 | +0.17% | open_in_new |
| Aug 04, 2025 | ☀ PRE | $153.79 | $153.79 | $134.94 | 2,112,600 | -14.04% | open_in_new |
| May 06, 2025 | ☀ PRE | $143.01 | $145.25 | $139.47 | 1,333,300 | -14.06% | open_in_new |
| Nov 04, 2024 | ☀ PRE | $164.85 | $173.81 | $170.85 | 802,900 | -3.14% | open_in_new |
| Aug 05, 2024 | ☀ PRE | $165.00 | $184.39 | $180.71 | 1,038,500 | -5.85% | open_in_new |
| May 06, 2024 | ☀ PRE | $145.50 | $159.18 | $156.94 | 800,500 | -2.58% | open_in_new |
| Feb 26, 2024 | ☀ PRE | $126.77 | $162.28 | $157.00 | 2,237,200 | +41.02% | open_in_new |
| Nov 06, 2023 | ☀ PRE | $112.00 | $114.77 | $103.77 | 1,464,800 | -15.05% | open_in_new |
| Aug 07, 2023 | ☀ PRE | $115.00 | $115.15 | $108.51 | 1,128,000 | -12.63% | open_in_new |
| May 08, 2023 | ☀ PRE | $83.71 | $87.76 | $87.65 | 305,500 | +4.05% | open_in_new |
| Feb 27, 2023 | ☀ PRE | $77.75 | $79.61 | $78.14 | 127,400 | -0.41% | open_in_new |
| Nov 07, 2022 | ☽ POST | $73.88 | $79.04 | $78.05 | 164,100 | +1.06% | open_in_new |
| Aug 08, 2022 | ☽ POST | $82.06 | $85.11 | $82.40 | 239,800 | -5.58% | open_in_new |
| May 09, 2022 | ☽ POST | $54.79 | $56.26 | $49.28 | 308,400 | +8.6% | open_in_new |
| Feb 28, 2022 | ☽ POST | $60.96 | $64.54 | $63.55 | 134,400 | +0.94% | open_in_new |
| Nov 08, 2021 | ☽ POST | $52.72 | $55.96 | $49.09 | 258,500 | -3.24% | open_in_new |
| Aug 09, 2021 | ☽ POST | $60.48 | $61.11 | $60.47 | 103,400 | -2.53% | open_in_new |
| May 10, 2021 | ☀ PRE | $69.85 | $71.79 | $65.89 | 108,100 | -6.91% | open_in_new |
| Mar 01, 2021 | ☀ PRE | $80.52 | $87.29 | $85.46 | 222,700 | +8.33% | open_in_new |
| Nov 09, 2020 | ☀ PRE | $42.14 | $45.25 | $41.90 | 231,100 | +3.1% | open_in_new |
| Aug 10, 2020 | ☀ PRE | $40.11 | $42.52 | $41.18 | 165,500 | +3.18% | open_in_new |
| May 04, 2020 | ☀ PRE | $45.37 | $50.00 | $49.80 | 150,100 | +7.54% | open_in_new |
| Mar 10, 2020 | ☽ POST | $52.91 | $54.00 | $53.99 | 115,400 | -7.54% | open_in_new |
| Aug 05, 2019 | ☽ POST | $43.79 | $44.99 | $42.76 | 149,000 | +2.9% | open_in_new |
| May 10, 2019 | ☽ POST | $32.68 | $36.00 | $35.94 | 102,800 | -0.61% | open_in_new |
| Mar 12, 2019 | ☀ PRE | $20.71 | $22.00 | $21.05 | 123,200 | +1.64% | open_in_new |
| Nov 05, 2018 | ☀ PRE | $21.25 | $23.50 | $22.23 | 39,300 | -1.94% | open_in_new |
| May 08, 2018 | ☀ PRE | $10.43 | $10.68 | $10.09 | 29,600 | -2.51% | open_in_new |
| Nov 14, 2017 | ☽ POST | $11.00 | $11.20 | $10.79 | 9,400 | -3.61% | open_in_new |
Earnings Count
30
Total earnings in dataset
Avg Abs. Movement
±6.30%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 144 | 20260526 | open_in_new SEC.gov |
| 8-K | 20260520 | open_in_new SEC.gov |
| 10-Q | 20260504 | open_in_new SEC.gov |
| 8-K | 20260504 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260504 | open_in_new SEC.gov |
Frequently asked about KRYS earnings
When does Krystal Biotech, Inc. report earnings next? expand_more
Krystal Biotech, Inc. (KRYS)'s next earnings date is estimated for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KRYS stock move after earnings? expand_more
Over 30 reports, KRYS has moved an average of ±6.30% the session after earnings, closing higher 43.3% of the time.
What was KRYS's biggest post-earnings move? expand_more
KRYS's largest post-earnings gain on record was +41.02% on Feb 26, 2024, and its largest decline was -15.05% on Nov 06, 2023.
Where can I find Krystal Biotech, Inc.'s SEC filings? expand_more
All of Krystal Biotech, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right